Isoproterenol
In clinical developmentAlso known as (±)-isoprenaline, Duo-Medihaler, Isoprenalina, Isoprenaline+12 more
(±)-isoprenaline, Duo-Medihaler, Isoprenalina, Isoprenaline, Isoprenalinum, Isopropyl noradrenaline, Isoprénaline, Isuprel, Medihaler-Iso, N-Isopropylnoradrenaline, N-Isopropylnorepinephrine, (±)-isoproterenol, 1-(3,4-dihydroxyphenyl)-2-(isopropylamino)ethanol, 1-(3,4-dihydroxyphenyl)-2-isopropylaminoethanol, Isoproterenol Hydrochloride, Isoproterenol Sulfate.
Recent clinical, regulatory, research and industry developments relating to this drug.
Sex Disparities in Hypoxic Vasodilation and Impact of Obesity
Exercise-induced Adrenergic Receptor Signaling as an Immune Adjuvant for Allogeneic Cell Therapies
Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences
Early Neurovascular Adaptations in Aging Women
Autoimmune Basis for Postural Tachycardia Syndrome
Hemispheric divergence of interoceptive processing across psychiatric disorders.
Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa
Augmented Interoceptive Exposure Training for the Fear of Food in Anorexia Nervosa
Decision Support for Intraoperative Low Blood Pressure
Adenosine Study in Paroxysmal Atrial Fibrillation
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Decision Support for Intraoperative Low Blood Pressure
Adenosine Study in Paroxysmal Atrial Fibrillation
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes1
Journals, researchers & institutions
- eLife1
- Adamic EM1
- Avery J1
- de la Cruz F1
- Khalsa S1
- Teed AR1
- Laboratory for Autonomic Neuroscience1
- Laboratory of Brain and Cognition1
- Laureate Institute for Brain Research1
- Semel Institute for Neuroscience and Human Behavior1
- University of Tulsa1
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials